Physician-scientist with executive experience in molecular diagnostics, including laboratory director and vice president roles leading clinical development, validation, and operation of molecular oncology diagnostics (IVD and CDx). Built companion diagnostics and clinical trial operations groups from ground up through two FDA Breakthrough Device Designations, multiple successful Investigational Device Exemptions, FDA approval of the first liquid biopsy panel, approval of multiple PMA and sPMA CDx devices in US, Japan, and EU, including co-developed and follow-on CDx. VP-level experience in clinical strategy, including clinical product development, diagnostic study design and execution, and data development. VP-level experience contributing to reimbursement strategy, including clinical lead for successful Medicare and private payer coverage efforts.